To the full analysis
Buyback calculator for Insmed
Insmed stock: key metrics
INSMInsmed had an operating margin of −194% and a return on invested capital (ROIC) of −52.2% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | −50.4% | −5,486.7% | −5,664.9% |
| 2007 | 92.3% | −271.5% | −265.1% |
| 2008 | 100.0% | −123.2% | −133.9% |
| 2009 | 100.0% | −83.6% | 1,140.9% |
| 2010 | 100.0% | −116.9% | −93.0% |
| 2011 | 100.0% | −1,397.3% | −1,350.8% |
| 2012 | no data | no data | no data |
| 2013 | 0.0% | −478.4% | −487.6% |
| 2014 | −191.6% | −759.7% | −688.3% |
| 2015 | no data | no data | no data |
| 2016 | no data | no data | no data |
| 2017 | no data | no data | no data |
| 2018 | 75.4% | −3,124.9% | −3,297.2% |
| 2019 | 82.3% | −172.4% | −186.4% |
| 2020 | 75.7% | −161.3% | −178.9% |
| 2021 | 76.6% | −199.0% | −230.6% |
| 2022 | 77.5% | −186.4% | −196.3% |
| 2023 | 78.5% | −232.5% | −245.6% |
| 2024 | 76.4% | −241.5% | −251.2% |
| 2025 | 79.4% | −194.0% | −210.5% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −100.0% | no data | −100.0% |
| 2007 | −100.0% | −90.3% | −100.0% |
| 2008 | 200.0% | no data | −100.0% |
| 2009 | 95.5% | −13.8% | 93.4% |
| 2010 | −3.3% | −14.7% | −3.3% |
| 2011 | −44.4% | −68.1% | −42.7% |
| 2012 | −34.2% | −63.5% | −26.9% |
| 2013 | −39.1% | −90.1% | −31.8% |
| 2014 | −42.5% | −36.9% | −34.3% |
| 2015 | −37.9% | −33.8% | −33.1% |
| 2016 | −100.0% | −50.1% | −74.1% |
| 2017 | −53.4% | −47.6% | −41.7% |
| 2018 | −100.0% | −51.5% | −53.6% |
| 2019 | −97.2% | −31.4% | −34.3% |
| 2020 | −100.0% | −31.4% | −36.9% |
| 2021 | −100.0% | −33.2% | −35.0% |
| 2022 | −100.0% | −28.1% | −29.1% |
| 2023 | 200.0% | −43.6% | −56.4% |
| 2024 | −100.0% | −48.7% | −45.1% |
| 2025 | −100.0% | −52.2% | −56.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 14 Feb 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.